Showing results (1741-1750 of 6,759) with videos related to

Sort By:
Pageof 676
European Journal of Endocrinology|June 2, 2019
The brown fat-secreted adipokine neuregulin 4 is decreased in human and murine chronic kidney diseaseSusan Kralisch, Annett Hoffmann, Nora Klöting, et al.
European Journal of Endocrinology|October 16, 2018
ANNIVERSARY REVIEW: Antithyroid drug therapy: 70 years laterHenry B Burch, David S Cooper
European Journal of Endocrinology|October 16, 2018
Should we avoid using ketoconazole in patients with severe Cushing’s syndrome and increased levels of liver enzymes?Marine Ollivier, Magalie Haissaguerre, Amandine Ferriere, et al.
European Journal of Endocrinology|October 17, 2018
Long-term treatment with pegvisomant: observations from 2090 acromegaly patients in ACROSTUDYMichael Buchfelder, Aart-Jan van der Lely, Beverly M K Biller, et al.
European Journal of Endocrinology|October 17, 2018
Noonan syndrome males display Sertoli cell-specific primary testicular insufficiencySophie Moniez, Catherine Pienkowski, Benoit Lepage, et al.
European Journal of Endocrinology|October 23, 1997
Effects of long-term total fasting and insulin on ob gene expression in obese patientsP H Andersen, K Kristensen, S B Pedersen, et al.
European Journal of Endocrinology|October 23, 1997
The steroid antagonist RU486 given at pro-oestrus induces hypersecretion of follicle-stimulating hormone from oestrus afternoon to early metoestrus in the ratJ E Sánchez-Criado, M Tébar, A Ruiz, et al.
European Journal of Endocrinology|April 16, 1998
Stimulation of erythropoietin secretion by continuous subcutaneous infusion of recombinant human GH in anemic patients with chronic renal failureM Sohmiya, K Ishikawa, Y Kato
European Journal of Endocrinology|April 16, 1998
Elevated insulin-like growth factor (IGF) binding protein (IGFBP)-2 and IGFBP-4 expression of leukemic T-cells is affected by autocrine/paracrine IGF-II action but not by IGF type I receptor expressionM W Elmlinger, M S Sanatani, M Bell, et al.
European Journal of Endocrinology|July 25, 2016
THERAPY OF ENDOCRINE DISEASE: Improvement of cardiovascular risk factors after adrenalectomy in patients with adrenal tumors and subclinical Cushing's syndrome: a systematic review and meta-analysisIrina Bancos, Fares Alahdab, Rachel K Crowley, et al.
Pageof 676